Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kathryn P Gray, Ph.D.

Concepts (285)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local14202092730.460 Why?
Antineoplastic Combined Chemotherapy Protocols142020117090.430 Why?
HIV-110202368500.370 Why?
Androgen Antagonists5201814420.330 Why?
Models, Statistical3200850700.320 Why?
Carcinoma, Renal Cell6201932170.290 Why?
HIV Seropositivity220239600.280 Why?
Prostatic Neoplasms102018113360.260 Why?
Patient Dropouts120084120.260 Why?
Aromatase220161470.250 Why?
Breast Neoplasms112020210170.230 Why?
Nitriles420209570.220 Why?
Disease-Free Survival6201968210.220 Why?
HIV Infections122023172750.220 Why?
Survival Analysis72019101120.220 Why?
Proto-Oncogene Proteins c-met220205670.210 Why?
Receptors, Estrogen4202022110.210 Why?
PTEN Phosphohydrolase2201811130.210 Why?
Kaplan-Meier Estimate12202064930.210 Why?
Receptors, Androgen2202010780.200 Why?
Estrogen Receptor alpha220165800.200 Why?
Cytidine Deaminase220142450.190 Why?
Lymphocytes, Tumor-Infiltrating2201910860.190 Why?
Ritonavir220083280.190 Why?
Tamoxifen320169630.190 Why?
Lead Poisoning120233210.180 Why?
Viral Load6200833210.180 Why?
Antineoplastic Agents, Hormonal5201815300.180 Why?
Central Nervous System Diseases320135200.170 Why?
HIV Integrase Inhibitors120221650.170 Why?
Anti-HIV Agents4202345040.160 Why?
Triazoles220159020.160 Why?
Neoplasm Metastasis6201949010.150 Why?
Retinoblastoma Binding Proteins120181010.150 Why?
HIV Protease Inhibitors320084320.150 Why?
RNA, Viral6202328360.150 Why?
Lead120238780.150 Why?
Testicular Neoplasms220148010.150 Why?
Radium12018720.150 Why?
Antiretroviral Therapy, Highly Active3200718950.150 Why?
Kidney Neoplasms3201943120.150 Why?
Mannose-Binding Lectin120081460.140 Why?
DNA Topoisomerases, Type II120171220.140 Why?
Gene Fusion120193540.140 Why?
Bone Diseases120204190.140 Why?
Randomized Controlled Trials as Topic42016101460.140 Why?
Reverse Transcriptase Inhibitors220046190.130 Why?
Secretory Leukocyte Peptidase Inhibitor12016230.130 Why?
DNA Mismatch Repair120194280.130 Why?
Data Interpretation, Statistical1200626900.130 Why?
Cancer Care Facilities120194240.130 Why?
Postmenopause3202025090.130 Why?
Taxoids220196680.130 Why?
Colonic Polyps120205510.130 Why?
Cystadenocarcinoma, Serous120194790.120 Why?
Ovary220189580.120 Why?
Chemotherapy, Adjuvant7201835270.120 Why?
Estrogen Receptor beta120151680.120 Why?
Mortality1200628850.120 Why?
Receptors, Progesterone2201811300.120 Why?
Middle Aged3520202195600.110 Why?
Cyclophosphamide2201622180.110 Why?
Insulin-Like Growth Factor Binding Protein 1120131250.110 Why?
Bone Density Conservation Agents120207940.110 Why?
Prostatectomy2201819560.110 Why?
Dideoxynucleosides120031310.110 Why?
Methotrexate2201617190.100 Why?
Seminoma120131340.100 Why?
Colonoscopy1202013880.100 Why?
Neoplasm Staging82019111520.100 Why?
Prognosis122020295580.100 Why?
Orchiectomy220144700.100 Why?
Tablets220231470.100 Why?
Aged2720201682170.100 Why?
Pyridones320237850.100 Why?
Humans5820247583810.100 Why?
Prostate-Specific Antigen6201925280.100 Why?
Chemokine CCL2120146040.100 Why?
Retroperitoneal Neoplasms120143290.090 Why?
Interleukin-8120146960.090 Why?
Female3720243903160.090 Why?
Androgens2201612910.090 Why?
Prostate1201817910.090 Why?
Alleles4201568950.090 Why?
Endometrial Neoplasms1201913570.090 Why?
Adenoma1202021480.090 Why?
Polymorphism, Single Nucleotide52020157730.090 Why?
Survival Rate62020127210.080 Why?
Neoplasms, Germ Cell and Embryonal120144940.080 Why?
Male3420243587420.080 Why?
Ubiquitin-Protein Ligases1201818880.080 Why?
Antibiotics, Antineoplastic120136750.080 Why?
Estrogens1201615200.080 Why?
Phenylthiohydantoin220202040.080 Why?
Pyrones12008350.080 Why?
Sarcoma1201917850.080 Why?
Tumor Suppressor Protein p531201829120.080 Why?
Mutation52020299150.070 Why?
Disease Progression62019134680.070 Why?
Adenocarcinoma2201563130.070 Why?
Adult2120242199160.070 Why?
Aged, 80 and over122020586810.070 Why?
HIV1200415810.070 Why?
Polyethylene Glycols1201311880.070 Why?
Vascular Endothelial Growth Factor A1201834800.070 Why?
Uterine Cervical Neoplasms1201920160.070 Why?
Treatment Outcome132020643790.070 Why?
TOR Serine-Threonine Kinases1201620570.070 Why?
CD4 Lymphocyte Count4200725690.070 Why?
Doxorubicin1201322090.070 Why?
Follow-Up Studies82020390600.070 Why?
Genotype62018129450.070 Why?
Bone Neoplasms1201825310.060 Why?
Tumor Suppressor Proteins1201628000.060 Why?
Tumor Burden3201818930.060 Why?
HLA Antigens1201113680.060 Why?
Likelihood Functions120089870.060 Why?
Infant72024360540.060 Why?
Endpoint Determination120085900.060 Why?
Acquired Immunodeficiency Syndrome1200421970.060 Why?
Proportional Hazards Models42018124400.060 Why?
Benzamides2202013680.060 Why?
Mass Screening1202054250.060 Why?
Didanosine120041510.060 Why?
Nucleic Acid Synthesis Inhibitors120041100.060 Why?
Time Factors82019398730.060 Why?
Adolescent122023878880.060 Why?
Computer Simulation2200862010.060 Why?
Antineoplastic Agents52020135910.060 Why?
Child102024798130.060 Why?
Child, Preschool72024420580.060 Why?
Hot Flashes220163280.050 Why?
Hydroxyurea120042820.050 Why?
Genetic Association Studies1201227170.050 Why?
Indinavir12003730.050 Why?
Rifabutin12003580.050 Why?
Statistics, Nonparametric1200828500.050 Why?
Lymph Nodes1201434850.050 Why?
Ovarian Neoplasms1201948760.050 Why?
Tumor Necrosis Factor-alpha1201443420.050 Why?
Retrospective Studies112023801700.050 Why?
Antibodies, Monoclonal1201991600.050 Why?
Clinical Trials, Phase III as Topic220168510.050 Why?
Lamivudine120233620.050 Why?
Genetic Variation1201665480.050 Why?
Risk Factors82020738060.050 Why?
Colorectal Neoplasms1202068520.050 Why?
Poland120201960.040 Why?
Piperazines2202225110.040 Why?
Austria120202060.040 Why?
Estradiol2201819330.040 Why?
Feasibility Studies2202351990.040 Why?
Drug Administration Schedule3201948390.040 Why?
Oxazines120223410.040 Why?
Combined Modality Therapy3201885300.040 Why?
Gene Expression Regulation, Neoplastic4201785060.040 Why?
Protein Kinase Inhibitors1201656290.040 Why?
Odds Ratio3201896500.040 Why?
Heterocyclic Compounds, 3-Ring120222780.040 Why?
Aging1200886510.040 Why?
Diamines12019590.040 Why?
Logistic Models32023132760.040 Why?
Health Literacy120244410.040 Why?
Clinical Trials, Phase I as Topic120193260.040 Why?
Cohort Studies62019412520.040 Why?
Drug Therapy, Combination4200862930.040 Why?
MAP Kinase Kinase Kinases120192560.040 Why?
Sensitivity and Specificity22014146410.040 Why?
High-Throughput Nucleotide Sequencing2202036150.040 Why?
Young Adult62023588080.040 Why?
Phthalazines120193820.040 Why?
Radioisotopes120184950.030 Why?
Tissue Array Analysis120185510.030 Why?
Incidence22020212730.030 Why?
Anthracyclines120192820.030 Why?
Lymphocyte Count120197780.030 Why?
Pyrimidinones120193830.030 Why?
Pyridines1200828600.030 Why?
Morpholines120195800.030 Why?
Indazoles120183020.030 Why?
Medical Oncology1200823120.030 Why?
Lymphatic Metastasis2201429430.030 Why?
Neoplasms, Hormone-Dependent120184120.030 Why?
Aminopyridines120195640.030 Why?
Sweating120161540.030 Why?
Risk Assessment42020238830.030 Why?
Drug Synergism1201917450.030 Why?
Hospitals, Pediatric1202418540.030 Why?
Up-Regulation2201441140.030 Why?
Estrone120162320.030 Why?
Body Mass Index12012128760.030 Why?
Software1200844160.030 Why?
Premenopause1201810380.030 Why?
Bone Remodeling120185790.030 Why?
Sulfonamides2201819730.030 Why?
Genes, Tumor Suppressor1201810550.030 Why?
Fluorescent Antibody Technique1201824700.030 Why?
Androstadienes120163480.030 Why?
Chromosome Aberrations1202017640.030 Why?
Follicle Stimulating Hormone120167250.030 Why?
Family1202431880.030 Why?
Minor Histocompatibility Antigens120142930.030 Why?
Luteinizing Hormone120168200.030 Why?
Oligopeptides1201811850.030 Why?
Anti-Retroviral Agents1202317800.030 Why?
Gonadotropin-Releasing Hormone1201811530.030 Why?
Estrogen Receptor Modulators12012580.030 Why?
Gene Expression Profiling2201994050.030 Why?
Colon1202017880.030 Why?
Registries2201981760.030 Why?
Forkhead Transcription Factors1201916110.030 Why?
RNA1202227160.020 Why?
Research Design1200861540.020 Why?
Early Detection of Cancer2201732110.020 Why?
Haplotypes1200827640.020 Why?
Microarray Analysis120147460.020 Why?
Tomography, X-Ray Computed12014205000.020 Why?
Parents1202435480.020 Why?
Proto-Oncogene Proteins c-akt1201924430.020 Why?
DNA, Neoplasm1201617450.020 Why?
Obesity12012128700.020 Why?
Cell Line, Tumor22017168860.020 Why?
Transcriptional Activation1201617530.020 Why?
Signal Transduction32019233410.020 Why?
Predictive Value of Tests22019152250.020 Why?
Antiviral Agents1202230560.020 Why?
DNA Mutational Analysis1201841060.020 Why?
Metabolic Diseases120166820.020 Why?
Virus Replication1200724300.020 Why?
Liposomes120137770.020 Why?
Pyrazoles1201919900.020 Why?
Repressor Proteins1201929800.020 Why?
Intercellular Signaling Peptides and Proteins1201616510.020 Why?
Aromatase Inhibitors120125110.020 Why?
Risk-Taking1200410340.020 Why?
Genetic Predisposition to Disease22020177680.020 Why?
Adiponectin1201311140.020 Why?
Mastectomy, Segmental120139720.020 Why?
Neoadjuvant Therapy1201828210.020 Why?
Radiographic Image Interpretation, Computer-Assisted1201412140.020 Why?
Algorithms12008139590.020 Why?
Lymph Node Excision1201313030.020 Why?
Case-Control Studies22018220310.020 Why?
Nephrectomy1201210160.020 Why?
Double-Blind Method22015122620.020 Why?
United States32020721400.020 Why?
Dose-Response Relationship, Drug12018107470.020 Why?
Pyrimidines1201830060.020 Why?
Immunohistochemistry12019110700.020 Why?
Cell Survival1201657810.020 Why?
Alanine Transaminase120086040.020 Why?
Leptin1201315910.020 Why?
Computational Biology1201735020.020 Why?
Health Services Accessibility1202354030.020 Why?
Blood Coagulation Disorders120083490.020 Why?
Vomiting120086510.020 Why?
Quality of Life22019132860.020 Why?
Clinical Competence1202047750.020 Why?
Genomics1202057890.010 Why?
Prospective Studies22019541360.010 Why?
Mastectomy1201318320.010 Why?
Anti-Bacterial Agents1200374030.010 Why?
Regression Analysis1200463530.010 Why?
DNA, Viral1201121940.010 Why?
Pandemics1202386110.010 Why?
Lung Neoplasms12008132450.010 Why?
Pain1201850650.010 Why?
Recurrence1201484260.010 Why?
Models, Biological1201894610.010 Why?
Mice, Knockout12017143540.010 Why?
Polymerase Chain Reaction1201160680.010 Why?
Diarrhea1200813170.010 Why?
Cognition1200869550.010 Why?
Cell Proliferation12016104170.010 Why?
Multivariate Analysis12013120960.010 Why?
RNA, Messenger12014127600.010 Why?
Area Under Curve1200316320.010 Why?
Drug Interactions1200314140.010 Why?
Comorbidity12013104950.010 Why?
Genome-Wide Association Study12017126040.010 Why?
Cross-Over Studies1200320480.010 Why?
Infant, Newborn12007261820.010 Why?
Reproducibility of Results12014200520.010 Why?
Mice12017811070.010 Why?
Animals120171677770.000 Why?
Gray's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (285)
Explore
_
Co-Authors (71)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.